Matches in Nanopublications for { ?s ?p "[Silencing of CX(3)CR1 reduced migration toward human ovarian carcinoma ascites fluid by approximately 70%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP741404.RAkevtSPTpzkOdrDADU3wzNzOcVIOlFCLSbZHYEvsNQp4130_assertion description "[Silencing of CX(3)CR1 reduced migration toward human ovarian carcinoma ascites fluid by approximately 70%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP741404.RAkevtSPTpzkOdrDADU3wzNzOcVIOlFCLSbZHYEvsNQp4130_provenance.
- NP338957.RArPSmOIdlLsdMNBT8B9SbnRCWMkAF-m9IDmiydEH0f1o130_assertion description "[Silencing of CX(3)CR1 reduced migration toward human ovarian carcinoma ascites fluid by approximately 70%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338957.RArPSmOIdlLsdMNBT8B9SbnRCWMkAF-m9IDmiydEH0f1o130_provenance.
- NP697101.RAnieMlWPuEqDrfkH9cJeyHrRVf8EFiGb3oHm1_q4gEOY130_assertion description "[Silencing of CX(3)CR1 reduced migration toward human ovarian carcinoma ascites fluid by approximately 70%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697101.RAnieMlWPuEqDrfkH9cJeyHrRVf8EFiGb3oHm1_q4gEOY130_provenance.
- assertion description "[Silencing of CX(3)CR1 reduced migration toward human ovarian carcinoma ascites fluid by approximately 70%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP338358.RAQ8NIBiyEOD7Pox2TKU_uE5RnGcx7GB-BSJVUTyRxOPQ130_assertion description "[Silencing of CX(3)CR1 reduced migration toward human ovarian carcinoma ascites fluid by approximately 70%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338358.RAQ8NIBiyEOD7Pox2TKU_uE5RnGcx7GB-BSJVUTyRxOPQ130_provenance.
- NP338452.RACrwe8aOS_vRc-zQ94wPnZOGW7ORflQblUDiiwxIKxYw130_assertion description "[Silencing of CX(3)CR1 reduced migration toward human ovarian carcinoma ascites fluid by approximately 70%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338452.RACrwe8aOS_vRc-zQ94wPnZOGW7ORflQblUDiiwxIKxYw130_provenance.
- NP936907.RACX-6VMT4YCcSlTeSspR5AH9IOH43_kVQN63dDUCuyJc130_assertion description "[Silencing of CX(3)CR1 reduced migration toward human ovarian carcinoma ascites fluid by approximately 70%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936907.RACX-6VMT4YCcSlTeSspR5AH9IOH43_kVQN63dDUCuyJc130_provenance.
- NP936908.RALm1VukxvTxT9ziUE3UhJKt3rpkEsgMMJJQ8BzFDtKuU130_assertion description "[Silencing of CX(3)CR1 reduced migration toward human ovarian carcinoma ascites fluid by approximately 70%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936908.RALm1VukxvTxT9ziUE3UhJKt3rpkEsgMMJJQ8BzFDtKuU130_provenance.